Healthcare AI Acquisition Corp. Announces Pricing of $200,000,000 Initial Public Offering

LONDON, Dec. 9, 2021 /PRNewswire/ -- Healthcare AI Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of entering in a combination with one or more businesses, today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market ("Nasdaq") and will begin trading tomorrow, Friday, December 10, 2021, under the ticker symbol "HAIAU."  Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Once the securities comprising the units begin separate trading, Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols "HAIA" and "HAIAW," respectively.

The Company is sponsored by Healthcare AI Acquisition, LLC, an affiliate of Stanley Capital. While the Company may pursue an initial business combination target in any industry or geographic region, it intends to focus its search on businesses in the healthcare and pharmaceutical industry, specifically companies within the e-Clinical, Healthcare Information Technology or Outsourced Pharmaceutical Services industries with high AI readiness and technological transformation potential.

Citigroup Global Markets Inc. and Jefferies LLC are serving as book-running managers for the offering. The Company has granted the underwriters a 45-day option to purchase up to 3,000,000 additional units at a price of $10.00 per unit to cover over-allotments, if any.

A registration statement relating to the securities of the Company has been filed with, and declared effective by, the U.S. Securities and Exchange Commission's (the "SEC") on December 9, 2021. The initial public offering is expected to close on December 14, 2021, subject to customary closing conditions.

The proposed offering is being made only by means of a prospectus, which forms a part of the registration statement. Copies of the prospectus relating to the offering may be obtained, when available, for free by visiting EDGAR on the SEC's website at www.sec.gov or by contacting Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone number 1-800-831-9146 or Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at (877) 821-7388 or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the initial public offering of the Company and its management. The statements involve risks and uncertainty. Words such as "anticipate," "estimate," "expect," "intend," "plan," and "project" and other similar words and expressions are intended to signify forward-looking statements. Forward-looking statements are not guarantees of future results and conditions but rather are subject to various risks and uncertainties. Such statements are based on the Company's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Investors are cautioned that there can be no assurance actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various risks and uncertainties. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Investors should refer to the risks detailed from time to time in the reports the Company files or will file with the SEC for additional factors that could cause actual results to differ materially from those stated or implied by such forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.

Media Contacts:

Zach Kouwe/ Doug Allen
Dukas Linden Public Relations
[email protected]
212-704-7385

SOURCE Healthcare AI Acquisition Corp.